2
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Treatment of prostatic cancer

Newer forms of androgen deprivation

Pages 249-258 | Published online: 16 May 2016

References

  • Byar DP. Proceedings: the Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate. Cancer 1973: 32(Nov): 1126–30
  • Hedlund PO, Gustafson H, Sjögren S. Cardiovascular complications to treatment of prostatic cancer with estramustine phosphate (Estracyt) or conventional estrogen: a follow-up of 212 randomized patients. Scand J Urol Nephrol (Suppl) 1980: 55: 103–5
  • Schally AV. Arimura A, Baba Y, et al. Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun 1971: 43(2): 393–9
  • Wenderoth UD, Jacobi GH. Gonadotropin-releasirig hormone analogues for palliation of carcinoma of the prostate. World J Urol 1983: 1: 40–8
  • Soloway MS, Presant CA, Klioze S, et al. Buserelin as primary therapy in advanced prostatic carcinoma. Proc Am Soc Clin Oncol 1984: 3: 157
  • Schmidt JD, Scott WW, Gibbons R, et al. Chemotherapy programs of the National Prostatic Cancer Project. Cancer 1980: 45(7 Suppl): 1937–46
  • The Lenprolide Study Group. Leuprolide versus diethylstllbestrol for metastatic prostatic cancer. N Engl J Med 1984: 311(20): 1281–6
  • Jacobi GH, Altwein JE, Kurth KH, et al. Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomized trial. Br J Urol 1980: 52(3): 208–15
  • Schroeder FH. Treatment of prostatic cancer: the EORTC experience—preliminary results of prostatic carcinoma trials. Prostate 1984: 5(2): 193–8
  • Sogani PC, Vagaiwala MR, Whitmore WF Jr. Experience with flutamide In patients with advanced prostatic cancer without prior endocrine therapy. Cancer 1984: 54(4): 744–50
  • Jacobo E, Schmidt JD, Weinstein SH, et al. Comparison of flutamide (SCH- 13521) and diethylstilbestrol in untreated advanced prostatic cancer. Urology 1976: 8(3): 231–3
  • Prout GR Jr, Irwin RJ Jr, Kliman B, et al. Prostatic cancer and SCH-13521: histological alterations and pituitary gonadal axis. J Urol 1975: 113(6): 834–40
  • Geller J, Albert J, Ten SS. Treatment of advanced cancer of the prostate with megestrol acetate. Urology 1978: 12(5): 537–41
  • Johnson DE, Kaesler K, Ayala AG. Megestrol acetate for treatment of advanced carcinoma of the prostate. J Surg Oncol 1975: 7(1): 9–15

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.